InnovAge Holding Dirección

Dirección controles de criterios 3/4

El CEO de InnovAge Holding's es Patrick Blair , nombrado en Dec 2021, tiene una permanencia de 2.33 años. compensación anual total es $1.51M, compuesta por 49.8% salario y 50.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.38% de las acciones de la empresa, por valor de $2.04M. La antigüedad media del equipo directivo y de la junta directiva es de 1.4 años y 3.1 años, respectivamente.

Información clave

Patrick Blair

Chief Executive Officer (CEO)

US$1.5m

Compensación total

Porcentaje del salario del CEO	49.8%
Permanencia del CEO	2.3yrs
Participación del CEO	0.4%
Permanencia media de la dirección	1.4yrs
Promedio de permanencia en la Junta Directiva	3.1yrs

Actualizaciones recientes de la dirección

Recent updates

InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?

Mar 15

Market Still Lacking Some Conviction On InnovAge Holding Corp. (NASDAQ:INNV)

Jan 06

InnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 73% Above Its Share Price

Aug 10

Cautious Investors Not Rewarding InnovAge Holding Corp.'s (NASDAQ:INNV) Performance Completely

Jun 08

InnovAge GAAP EPS of -$0.09 misses by $0.06, revenue of $172.86M misses by $1.11M

Sep 13

InnovAge names Richard Feifer as chief medical officer

Aug 17

InnovAge Holding (NASDAQ:INNV) Could Be Struggling To Allocate Capital

Jul 27

Earnings Miss: InnovAge Holding Corp. Missed EPS And Analysts Are Revising Their Forecasts

May 12

Here's What's Concerning About InnovAge Holding's (NASDAQ:INNV) Returns On Capital

Apr 14

Is There An Opportunity With InnovAge Holding Corp.'s (NASDAQ:INNV) 30% Undervaluation?

Mar 24

InnovAge Pursues Compliance As Precursor To Post-Pandemic Growth

Mar 19

InnovAge Holding's (NASDAQ:INNV) Robust Earnings Are Supported By Other Strong Factors

Nov 16

Are Investors Undervaluing InnovAge Holding Corp. (NASDAQ:INNV) By 48%?

Jul 28

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Patrick Blair en comparación con los beneficios de InnovAge Holding?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	-US$32m
Sep 30 2023	n/a	n/a	-US$38m
Jun 30 2023	US$2m	US$750k	-US$41m
Mar 31 2023	n/a	n/a	-US$42m
Dec 31 2022	n/a	n/a	-US$38m
Sep 30 2022	n/a	n/a	-US$27m
Jun 30 2022	US$8m	US$438k	-US$7m

Compensación vs. Mercado: La compensación total de Patrick($USD1.51M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD2.37M).

Compensación vs. Ingresos: La compensación de Patrick ha sido consistente con los resultados de la empresa en el último año.

CEO

Patrick Blair (52 yo)

2.3yrs

Permanencia

US$1,506,600

Compensación

Mr. Patrick Blair serves as President of InnovAge Holding Corp. since December 1, 2021 and as its CEO since January 01, 2022. He had been the Chief Marketing Officer and Senior Vice President of Commercial...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Patrick Blair	President & CEO	2.3yrs	US$1.51m	0.38% $ 1.9m
Nicole D'Amato	Chief Legal Officer & Corporate Secretary	2.8yrs	US$1.48m	0.035% $ 180.8k
Richard Feifer	Chief Medical Officer	1.7yrs	US$1.39m	0.016% $ 80.3k
Edward Kennedy	Independent Director	no data	US$100.00k	0.017% $ 87.4k
Marilyn Tavenner	Independent Director	no data	US$120.00k	sin datos
Benjamin Adams	Chief Financial Officer	less than a year	sin datos	sin datos
Christine Bent	Chief Operations Officer	1.1yrs	sin datos	0.092% $ 477.1k
Cara Babachicos	Chief Information Officer	1.1yrs	sin datos	sin datos
Ryan Kubota	Director of Investor Relations	no data	sin datos	sin datos
Olivia Patton	Chief Compliance Officer	no data	sin datos	sin datos
Matt Huray	Chief Strategy & Corporate Development Officer	less than a year	sin datos	sin datos
Rob Borella	Chief Sales & Marketing Officer	1.7yrs	sin datos	sin datos

1.4yrs

Permanencia media

56yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de INNV no se considera experimentado ( 1.4 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Edward Kennedy	Independent Director	3.1yrs	US$100.00k	0.017% $ 87.4k
Marilyn Tavenner	Independent Director	3.1yrs	US$120.00k	sin datos
Andrew Cavanna	Director	3.1yrs	sin datos	sin datos
James Carlson	Independent Non-Executive Chairman	1.8yrs	US$200.00k	0.021% $ 108.4k
Thomas Scully	Director	3.1yrs	sin datos	0.074% $ 380.0k
Richard Zoretic	Independent Director	3.1yrs	US$120.00k	sin datos
John Bush	Independent Director	3.1yrs	US$100.00k	sin datos
Teresa Sparks	Independent Director	less than a year	sin datos	sin datos
Patricia Fontneau	Independent Director	1.1yrs	US$125.00k	sin datos

3.1yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: La junta directiva de INNV se considera experimentada (3.1 años de antigüedad promedio).

InnovAge Holding Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2023

Innovage Holding Corp. Names Darlene Flaig as New Chief Nursing Officer

InnovAge Holding Corp. Announces the Appointment of Teresa Sparks to Its Board of Directors

InnovAge Holding Corp. Announces CFO Changes

High number of new and inexperienced directors

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2022

Recent updates

InnovAge Holding Corp. to Report Q3, 2024 Results on May 07, 2024

InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?

Price target decreased by 9.3% to US$6.50

Consensus EPS estimates fall by 18%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

InnovAge Holding Corp. Provides Earnings Guidance for the Full Fiscal Year 2024

InnovAge Holding Corp. to Report Q2, 2024 Results on Feb 06, 2024

Market Still Lacking Some Conviction On InnovAge Holding Corp. (NASDAQ:INNV)

Consensus EPS estimates fall by 113%

Consensus EPS estimates fall by 127%, revenue upgraded

First quarter 2024 earnings: EPS misses analyst expectations

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2023

InnovAge Holding Corp. to Report Q1, 2024 Results on Nov 07, 2023

Innovage Holding Corp. Names Darlene Flaig as New Chief Nursing Officer

Consensus EPS estimates fall by 60%

Price target decreased by 8.3% to US$7.33

InnovAge Holding Corp. Provides Full Fiscal Year 2024 Financial Guidance

Full year 2023 earnings: EPS misses analyst expectations

InnovAge Holding Corp. to Report Q4, 2023 Results on Sep 12, 2023

InnovAge Holding Corp. Announces the Appointment of Teresa Sparks to Its Board of Directors

InnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 73% Above Its Share Price

Now 21% undervalued

InnovAge Holding Corp. Announces CFO Changes

Now 20% undervalued after recent price drop

InnovAge Holding Corp.(NasdaqGS:INNV) dropped from Russell Small Cap Comp Value Index

Cautious Investors Not Rewarding InnovAge Holding Corp.'s (NASDAQ:INNV) Performance Completely

Now 24% undervalued after recent price drop

Third quarter 2023 earnings: EPS misses analyst expectations

Consensus EPS estimates upgraded to US$0.24 loss

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

InnovAge Holding Corp. to Report Q2, 2023 Results on Feb 07, 2023

Price target increased to US$7.00

High number of new and inexperienced directors

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2022

InnovAge Holding Corp. to Report Q1, 2023 Results on Nov 08, 2022

InnovAge Holding Corp. Not Provides Earnings Guidance for the Fiscal Year 2023

Investor sentiment improved over the past week

InnovAge GAAP EPS of -$0.09 misses by $0.06, revenue of $172.86M misses by $1.11M

InnovAge Holding Corp. to Report Q4, 2022 Results on Sep 13, 2022

InnovAge Holding Corp. Appoints Kathy Andreasen as Chief People Officer

InnovAge Holding Corp. Names Richard Feifer as Chief Medical Officer

InnovAge names Richard Feifer as chief medical officer

InnovAge Holding (NASDAQ:INNV) Could Be Struggling To Allocate Capital

InnovAge Appoints James Carlson to Its Board of Directors and as Non-Executive Chairman

Investor sentiment deteriorated over the past week

Consensus forecasts updated

Price target decreased to US$4.70

Earnings Miss: InnovAge Holding Corp. Missed EPS And Analysts Are Revising Their Forecasts

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Here's What's Concerning About InnovAge Holding's (NASDAQ:INNV) Returns On Capital

Is There An Opportunity With InnovAge Holding Corp.'s (NASDAQ:INNV) 30% Undervaluation?

Price target decreased to US$5.00

Less than half of directors are independent

InnovAge Pursues Compliance As Precursor To Post-Pandemic Growth

Kaskela Law LLC Announces Class Action Lawsuit Against Innovage Holding Corp. and Encourages Long-Term Investors to Contact the Firm

InnovAge Holding Corp. to Report Q2, 2022 Results on Feb 09, 2022

InnovAge Holding Corp. Withdraws Fiscal Year 2022 Guidance

Investor sentiment deteriorated over the past week

InnovAge Holding's (NASDAQ:INNV) Robust Earnings Are Supported By Other Strong Factors

First quarter 2022 earnings released: EPS US$0.057 (vs US$0.15 loss in 1Q 2021)

Full year 2021 earnings released: US$0.36 loss per share (vs US$0.20 profit in FY 2020)

InnovAge Holding Corp. Provides Earnings Guidance for the Full Fiscal Year 2022

Are Investors Undervaluing InnovAge Holding Corp. (NASDAQ:INNV) By 48%?

Third quarter 2021 earnings released: US$0.087 loss per share (vs US$0.076 profit in 3Q 2020)

InnovAge Holding Corp. Provides Revenue Guidance for the Fourth Quarter and Full Year of Fiscal 2021

President recently bought US$249k worth of stock

InnovAge Holding Corp. Announces Board Appointments

InnovAge Holding Corp. has completed an IPO in the amount of $350.000007 million.